Oncolys BioPharma is a public clinical-stage company developing oncolytic viruses. OBP-301 is the first-in-class oncolytic adenovirus for Esophageal Cancer. We are also developing HDAC inhibitor and small molecule anti-SARS-Cov-2, and cancer diagnostic
)
)
)
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
